Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Denizcan Güven"'
Autor:
Metin Demir, Denizcan Güven, Burak Yasin Aktaş, Gürkan Güner, Oktay Halit Aktepe, Hakan Taban, Yusuf Karakaş, Sadettin Kılıçkap, Ayşe Kars, Alev Türker, Ömer Dizdar
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 04, Pp 287-292 (2022)
Objective Liposarcomas are relatively rare tumors. Prognostic and predictive factors and treatment options are limited. We herein presented our 10-year experience with liposarcomas. Materials and Methods Adult patients with liposarcoma treated betwee
Externí odkaz:
https://doaj.org/article/d48e7724c2054aaea29d505e552abdc2
Autor:
Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er, Muhammed Mustafa Atci, Atakan Topçu, Gökhan Uçar, Baran Akagündüz, Musa Bariş Aykan, Miraç Özen, Naziyet Köse Baytemur, Melike Özçelik, Elif Şahin, Denizcan Güven, Serkan Menekşe, Naziye Ak, Fatih Teker, Engin Kut, Teoman Şakalar, Özkan Alan, Turgut Kaçan, Nazim Serdar Turhal, Saadettin Kiliçkap, Sema Türker, Mehmet Ali Nahit Şendur, Osman Köstek, Mustafa Karaağaç, Abdullah Sakin, Haci Mehmet Türk, Dilek Çağlayan, Şener Cihan, Yusuf Açikgöz, Doğan Uncu
Publikováno v:
Biomolecules & Biomedicine, Vol 22, Iss 5 (2022)
Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of HER2-positive metastatic gastric adenocarcinoma. However, there is no comprehensive study on which platinum-based treatment should be preferred.
Externí odkaz:
https://doaj.org/article/76c42bc31695447ca49b70652deb5b62
Autor:
Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er, Muhammed Mustafa Atci, Atakan Topçu, Gökhan Uçar, Baran Akagündüz, Musa Bariş Aykan, Miraç Özen, Naziyet Köse Baytemur, Melike Özçelik, Elif Şahin, Denizcan Güven, Serkan Menekşe, Naziye Ak, Fatih Teker, Engin Kut, Teoman Şakalar, Özkan Alan, Turgut Kaçan, Nazim Serdar Turhal, Saadettin Kiliçkap, Sema Türker, Mehmet Ali Nahit Şendur, Osman Köstek, Mustafa Karaağaç, Abdullah Sakin, Haci Mehmet Türk, Dilek Çağlayan, Şener Cihan, Yusuf Açikgöz, Doğan Uncu
Publikováno v:
Bosnian Journal of Basic Medical Sciences.
Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of HER2-positive metastatic gastric adenocarcinoma. However, there is no comprehensive study on which platinum-based treatment should be preferred.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b31ae9793b038840ef1bd93ccf87e5e1
https://doi.org/10.17305/bjbms.2021.7069
https://doi.org/10.17305/bjbms.2021.7069